-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
When manufacturing therapeutic proteins, vaccines, and other biological products, pharmaceutical companies must purify active molecules from bacteria or mammalian host cells
This requires strict quality control
To this end, Bio-Rad has launched a new product-ddPCR™ Supermix for Residual DNA Quantification
Compared with real-time quantitative PCR technology, the advantage of using droplet digital PCR (ddPCR) technology and premix is that the DNA purification step can be skipped and the residual DNA of the host cell can be directly determined
At the same time, ddPCR technology directly counts the number of target molecules without the need to establish a standard curve, thus greatly simplifying the quantification of residual DNA
ddPCR™ Supermix for Residual DNA Quantification is provided at a concentration of 2x.
Bio-Rad's QX200 microdroplet digital PCR system was launched two years ago
Learn about the ddPCR platform and more applications of this technology